-+ 0.00%
-+ 0.00%
-+ 0.00%

PharmAla Biotech Signs Deal to Supply MDMA for Aalborg University Hospital PTSD Trial

PUBT·11/09/2026 12:32:34
Listen to the news
PharmAla Biotech Signs Deal to Supply MDMA for Aalborg University Hospital PTSD Trial
  • PharmAla Biotech signed an agreement to exclusively supply LaNeo MDMA to Aalborg University Hospital for Denmark's MIRROR PTSD trial.
  • The hospital will pay cash and grant nonexclusive, perpetual, worldwide rights to trial data for regulatory and commercial use, including sublicensing.
  • The trial will compare MDMA-assisted psychotherapy with MDMA-assisted music relaxation for service-related PTSD.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharmala Biotech Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611090730PRIMZONEFULLFEED9871638) on November 09, 2026, and is solely responsible for the information contained therein.